Allcyte
Vienna
About Allcyte
Allcyte is a biotech start-up company focused on functional drug testing in primary human material. With our Pharmacoscopy high-content imaging platform and AI-supported image analysis pipelines, our mission is to bring the next generation of personalized medicine to cancer patients and treating physicians, and support pharmaceutical companies to focus their drug development efforts on the right molecules in the right indications. We enable research through the image-based quantification of single-cell phenotypes - all performed directly in primary patient material with minimal amounts of manipulation and requiring minimal amounts of sample. We integrate these data using cutting edge methods of statistics and machine learning to generate actionable insights for our customers. Our mission is to help you make the best possible biomedical decisions.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.0M
- Funding stage: M&A
- Last round: Grant (Jul 2020)
- Website: allcyte.com
- Phone: +43 1 398 2020
Industries & Categories
Biotechnology, Health Diagnostics, Machine Learning, Pharmaceutical, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/allcyte-69904 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.